Literature DB >> 10665486

The spectrum of mutations causing end-plate acetylcholinesterase deficiency.

K Ohno1, A G Engel, J M Brengman, X M Shen, F Heidenreich, A Vincent, M Milone, E Tan, M Demirci, P Walsh, S Nakano, I Akiguchi.   

Abstract

The end-plate species of acetylcholinesterase (AChE) is an asymmetric enzyme consisting of a collagenic tail subunit composed of three collagenic strands (ColQ), each attached to a tetramer of the T isoform of the catalytic subunit (AChE(T)) via a proline-rich attachment domain. The principal function of the tail subunit is to anchor asymmetric AChE in the synaptic basal lamina. Human end-plate AChE deficiency was recently shown to be caused by mutations in COLQ. We here report nine novel COLQ mutations in 7 patients with end-plate AChE deficiency. We examine the effects of the mutations on the assembly of asymmetric AChE by coexpressing each genetically engineered COLQ mutant with ACHE(T) in COS cells. We classify the newly recognized and previously reported COLQ mutations into four classes according to their position in ColQ and their effect on AChE expression. We find that missense mutations in the proline-rich attachment domain abrogate attachment of catalytic subunits, that truncation mutations in the ColQ collagen domain prevent the assembly of asymmetric AChE, that hydrophobic missense residues in the C-terminal domain prevent triple helical assembly of the ColQ collagen domain, and that other mutations in the C-terminal region produce asymmetric species of AChE that are likely insertion incompetent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10665486

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  20 in total

1.  Protein-anchoring strategy for delivering acetylcholinesterase to the neuromuscular junction.

Authors:  Mikako Ito; Yumi Suzuki; Takashi Okada; Takayasu Fukudome; Toshiro Yoshimura; Akio Masuda; Shin'ichi Takeda; Eric Krejci; Kinji Ohno
Journal:  Mol Ther       Date:  2012-02-28       Impact factor: 11.454

2.  Trimerization domain of the collagen tail of acetylcholinesterase.

Authors:  Suzanne Bon; Annick Ayon; Jacqueline Leroy; Jean Massoulié
Journal:  Neurochem Res       Date:  2003-04       Impact factor: 3.996

Review 3.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

4.  Functional consequences and structural interpretation of mutations of human choline acetyltransferase.

Authors:  Xin-Ming Shen; Thomas O Crawford; Joan Brengman; Gyula Acsadi; Susan Iannaconne; Emin Karaca; Chaouky Khoury; Jean K Mah; Shimon Edvardson; Zeljko Bajzer; David Rodgers; Andrew G Engel
Journal:  Hum Mutat       Date:  2011-09-23       Impact factor: 4.878

Review 5.  Congenital myasthenic syndromes: genetic defects of the neuromuscular junction.

Authors:  Kinji Ohno; Andrew G Engel
Journal:  Curr Neurol Neurosci Rep       Date:  2002-01       Impact factor: 5.081

6.  Neuromuscular junction acetylcholinesterase deficiency responsive to albuterol.

Authors:  Sophelia H S Chan; Virginia C N Wong; Andrew G Engel
Journal:  Pediatr Neurol       Date:  2012-08       Impact factor: 3.372

7.  COOH-terminal collagen Q (COLQ) mutants causing human deficiency of endplate acetylcholinesterase impair the interaction of ColQ with proteins of the basal lamina.

Authors:  Juan Arredondo; Marian Lara; Fiona Ng; Danielle A Gochez; Diana C Lee; Stephanie P Logia; Joanna Nguyen; Ricardo A Maselli
Journal:  Hum Genet       Date:  2013-11-27       Impact factor: 4.132

8.  Congenital myasthenic syndromes in Turkey: Clinical clues and prognosis with long term follow-up.

Authors:  Hacer Durmus; Xin-Ming Shen; Piraye Serdaroglu-Oflazer; Bulent Kara; Yesim Parman-Gulsen; Coskun Ozdemir; Joan Brengman; Feza Deymeer; Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2017-11-28       Impact factor: 4.296

9.  Assembly and regulation of acetylcholinesterase at the vertebrate neuromuscular junction.

Authors:  R L Rotundo; C A Ruiz; E Marrero; L M Kimbell; S G Rossi; T Rosenberry; A Darr; P Tsoulfas
Journal:  Chem Biol Interact       Date:  2008-05-27       Impact factor: 5.192

10.  Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions.

Authors:  Jasmina Minic; Arnaud Chatonnet; Eric Krejci; Jordi Molgó
Journal:  Br J Pharmacol       Date:  2003-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.